David A. Siegel Merus N.V. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Merus N.V. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 729,800 shares of MRUS stock, worth $30.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

729,800

Previous 817,800 10.76%

Holding current value

$30.5 Million

Previous $48.4 Million 24.65%

% of portfolio

0.09%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$47.19 - $58.84 $4.15 Million - $5.18 Million	-88,000 Reduced 10.76%	729,800 $36.5 Million
Q2 2024 Aug 14, 2024	BUY	$39.81 - $60.2 $3.95 Million - $5.98 Million	99,300 Added 13.82%	817,800 $48.4 Million
Q1 2024 May 15, 2024	BUY	$28.03 - $51.82 $8.04 Million - $14.9 Million	287,000 Added 66.51%	718,500 $32.4 Million
Q4 2023 Feb 14, 2024	BUY	$20.06 - $28.66 $4.26 Million - $6.09 Million	212,400 Added 96.94%	431,500 $11.9 Million
Q3 2023 Nov 14, 2023	BUY	$20.13 - $27.29 $424,743 - $575,819	21,100 Added 10.66%	219,100 $5.17 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $636,050 - $943,146	34,700 Added 21.25%	198,000 $5.21 Million
Q1 2023 May 15, 2023	SELL	$14.25 - $20.5 $116,850 - $168,100	-8,200 Reduced 4.78%	163,300 $3 Million
Q4 2022 Feb 14, 2023	BUY	$12.8 - $23.66 $711,680 - $1.32 Million	55,600 Added 47.97%	171,500 $2.65 Million
Q3 2022 Nov 14, 2022	SELL	$18.64 - $28.93 $123,024 - $190,938	-6,600 Reduced 5.39%	115,900 $2.32 Million
Q2 2022 Aug 15, 2022	SELL	$13.98 - $29.25 $138,402 - $289,575	-9,900 Reduced 7.48%	122,500 $2.77 Million
Q1 2022 May 16, 2022	SELL	$23.58 - $30.91 $2.49 Million - $3.27 Million	-105,700 Reduced 44.39%	132,400 $3.5 Million
Q4 2021 Feb 14, 2022	SELL	$20.0 - $32.29 $18,000 - $29,061	-900 Reduced 0.38%	238,100 $7.57 Million
Q3 2021 Nov 15, 2021	SELL	$16.48 - $27.23 $1.54 Million - $2.55 Million	-93,600 Reduced 28.14%	239,000 $5.26 Million
Q2 2021 Aug 16, 2021	BUY	$20.0 - $25.48 $2.46 Million - $3.14 Million	123,100 Added 58.76%	332,600 $7.01 Million
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $968,400 - $1.75 Million	60,000 Added 40.13%	209,500 $4.38 Million
Q4 2020 Feb 16, 2021	BUY	$11.4 - $18.36 $517,560 - $833,544	45,400 Added 43.61%	149,500 $2.62 Million
Q3 2020 Nov 16, 2020	BUY	$10.57 - $16.0 $439,712 - $665,600	41,600 Added 66.56%	104,100 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$10.5 - $17.36 $203,700 - $336,784	19,400 Added 45.01%	62,500 $1.01 Million
Q1 2020 May 15, 2020	BUY	$11.34 - $19.44 $44,226 - $75,816	3,900 Added 9.95%	43,100 $522,000
Q4 2019 Feb 14, 2020	BUY	$14.08 - $18.5 $551,936 - $725,200	39,200 New	39,200 $552,000

Others Institutions Holding MRUS

# of Institutions

200

Shares Held

61.9M

Call Options Held

243K

Put Options Held

300K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.92B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account